HPV vaccination policies in Slovenia
|
|
- Prudence Booth
- 6 years ago
- Views:
Transcription
1 HPV vaccination policies in Slovenia Country: Slovenia Partner Institute: Institute of Public Health of the Republic of Slovenia, Ljubljana Survey no: (12) 2008 Author(s): Tit Albreht Health Policy Issues: Public Health, New Technology, Long term care, System Organisation/ Integration, Political Context, Quality Improvement, Benefit Basket, Remuneration / Payment, HR Training/Capacities Current Process Stages Idea Pilot Policy Paper Legislation Implementation Evaluation Change 1. Abstract Initiatives for HPV vaccine reimbursement from public funds were launched early in As it had not materialised, civil society initiative groups organised funding in several municipalities from local public sources. But the pressure on a national decision mounted, also through the involvement of women MPs. The Minister of Health commissioned an opinion from the National Institute of Public Health which was presented at the Health Council. There the proposal was provisionally approved. 2. Purpose of health policy or idea The idea is to include HPV vaccine into regular funding from public sources. Concurrently, it would become part of the regular national immunisation programme. Pressure groups, which were organised within the civil society, together with the support of the influential women politicians and other important figures, proposed this step as a necessary fulfilment of women's right to health. This proposal followed the previous reimbursement of HPV vaccinations by several municipalities. There were two main controversial points around this proposal: 1. the extremely high cost of vaccine, which would exceed the total sum of all other vaccinations in the current national immunisation programme, 2. uncertainties surrounding the duration of the longterm protection, the role of catch-up cohorts and the effects in the system regarding cervical cancer screening. As HTA capacity in Slovenia is currently minimal and since public pressure was rising, it was difficult to imagine a consistent national HTA study for the HPV vaccine. The National Institute of Public Health (NIPH) presented a proposal of the introduction of a regular, non-compulsory, but publicly reimburseable national vaccination programme for HPV, involving complete vaccination of 12 year old girls. In the original proposal catch-up cohorts were not mentioned. The total cost of vaccinating around 10,000 girls with the three doses each would be just under 3 million Euro - an amount that would exceed the total of all other current vaccinations under the national vaccination programme
2 Cervical cancer - very rare in Slovenia An additional concern was that due to an intensified screening programme for cervical cancer, both incidence and mortality are declining anyway - in 2006, there were around 150 incident cases of invasive cervical cancer and 35 deaths, making cervical cancer a rather rare disease in Slovenia. The proposal of the NIPH was circulated through the so-called 'Broader Professional Colleges', which are consultative professional bodies of the Ministry of Health. After their individual decisions were taken the proposal was presented to the main consultative body of the Minister of Health, the Health Council. After some controversy in the discussion, the decision of provisionally approving the inclusion of HPV vaccination in the public funding scheme was reached, but pending some preconditions: 1. determination of the number of catch-up cohorts, 2. calculation of the potential caveats, esp. possible undesirable declines in screening coverage, 3. comparative analysis of the two existing vaccines and proposing the more cost-efficient one, 4. deciding on the possible later beginning of vaccination (given the sexual initiation age in Slovenia) and the decision on revaccinations. The analysis of these four points is expected to be ready by the end of November when it will be submitted to the Health Council for the second round of consultations. Main objectives Introduction of a publicly reimbursed non-compulsory vaccination against HPV infection Definition of the target population for vaccination by determining the initial age for primary vaccination, for revaccination and for catch-up cohorts Type of incentives The main financial incentive is to have the entire target population of girls vaccinated against HPV covered by compulsory health insurance. Groups affected Health Insurance Institute of Slovenia, Pre-pubertal and adolescent girls in Slovenia, Health care providers 3. Characteristics of this policy Degree of Innovation traditional innovative Degree of Controversy consensual highly controversial Structural or Systemic Impact marginal fundamental Public Visibility very low very high Transferability strongly system-dependent system-neutral - 2 -
3 4. Political and economic background There was pure contextual pressure, given the international expertise and example and following the nationally wellorganised civil society groups, supported by women politicians and other influential public figures. This pressure targetted both on professional groups and on the scientific community as well as on the political arena. The main problem in this issue is the rather expensive vaccine, which will represent a significant additional financial burden and will effectively indirectly affect other newly proposed programmes. A balance and a compromise solution will have to be found bearing these caveats in mind. Complies with Other - Following the trends in several other countries and the international developments in general, including the existing guidelines for HPV vaccination (ECDC and ACS). Change based on an overall national health policy statement Favouring policies that are evidence-based and proven to bring a significant improvement in the quality of life and survival. 5. Purpose and process analysis Idea Pilot Policy Paper Legislation Implementation Evaluation Change Origins of health policy idea The initiative and the approval process are a result of a systematic lobbying by the pharmaceutical companies through different pressure groups. Following approvals in other countries the pressure mounted, although there is not universal agreement across different medical specialties about its justification. Public health experts warn of the following consequences: 1. a potential threat to the existing sexual and reproductive health promotion campaigns 2. a decline in screening coverage rates 3. too early onset of vaccination in life may later require early (and therefore also unnecessary revaccinations) 4. extremely high costs per intervention, including an expected very high cost per QALY (and rising). Initiators of idea/main actors Civil Society Approach of idea The approach of the idea is described as: new: Innovation or pilot project Local level - municipalities - 3 -
4 Stakeholder positions The Ministry of Health was faced with an almost unprecedented pressure to rapidly introduce publicly reimbursed HPV vaccination of girls aged 12 or 13 years. The main concern was about the extremely high costs of vaccine and the related complex information system that would be needed to support adequate monitoring. The Minister of Health decided to gain some extra time by opening a wide professional consultation in this matter. Opportunity costs The Health Insurance Institute of Slovenia (HIIS) was reserved in this matter as they would be the main financier of this introduction as the national budget cannot accommodate such interventions. It is clear that introducing this vaccination would reduce the available financing for any other additional programmes that are usually approved later in the year. In this sense approving HPV vaccination will indirectly affect certain other patient categories. The pharmaceutical industry obviously played a partly overt and partly covert lobbying role in the process, supporting civil groups and, in some instances, even the NIPH. This led to very energetic reactions of the Ministry of Health, resulting in a step back in these activities. Actors and positions Description of actors and their positions Civil Society Kala - civil initiative group very supportive strongly opposed Women parliamentarians very supportive strongly opposed Influential public personalities very supportive strongly opposed Gynaecologists very supportive strongly opposed Influences in policy making and legislation No, there will be no formal piece of legislation. However, as a consequence of approving the vaccine for public reimbursement, the vaccination will then be included in the annual national immunisation programme, which is published as a by-law by the Ministry of Health. Legislative outcome pending Actors and influence Description of actors and their influence Civil Society Kala - civil initiative group very strong none Women parliamentarians very strong none Influential public personalities very strong none Gynaecologists very strong none Positions and Influences at a glance - 4 -
5 Monitoring and evaluation Monitoring and evaluation of the introduced HPV vaccination programme are not yet clearly defined. It is clear that monitoring of both the vaccinated girls/women as well as of those who are not going to be vaccinated will be needed in order to support an intense screening programme, which will have to remain available for all women, regardless of their vaccination status against HPV. 6. Expected outcome It is expected that, due to the examples of several other countries and the mounting public pressure in this matter, public funding for basic vaccination of 12-year-old girls will be approved and included in the regular immunisation programme from 2010 onwards. A consistent information system will have to be established for the monitoring of coverage and for the reporting of screening coverage for the vaccinated girls/women. This will have to be linked to the existing cancer registry at the Institute of Oncology in Ljubljana. Only such a supportive system in place will help the efficient and effective monitoring of the effects of a HPV vaccination programme. Quality of Health Care Services marginal fundamental Level of Equity system less equitable system more equitable Cost Efficiency very low very high - 5 -
6 7. References Sources of Information 1. Proposal for HPV vaccination in Slovenia. Institute of Public Health of the Republic of Slovenia Opinions of the Broader Professional Colleges (public health, pathology, microbiology, paediatrics and family medicine) on the inclusion of HPV vaccination into a public funding scheme Author/s and/or contributors to this survey Tit Albreht Suggested citation for this online article Tit Albreht. "HPV vaccination policies in Slovenia". Health Policy Monitor, October Available at -
Screening for bowel cancer
Screening for bowel cancer Country: United Kingdom Partner Institute: London School of Economics and Political Science Survey no: (5)2005 Author(s): Adam Oliver Health Policy Issues: New Technology, Quality
More informationMandating Body Mass Index Reporting in the Schools
Mandating Body Mass Index Reporting in the Schools Country: USA Partner Institute: Department of Behavioral Science and Health Education, Rollins School of Public Health, Emory University Survey no: (15)
More informationEvery Opportunity in Partnership.. Child & Family Service working in Partnership to increase Human Papilloma Virus (HPV) coverage rates
Every Opportunity in Partnership.. Child & Family Service working in Partnership to increase Human Papilloma Virus (HPV) coverage rates Lorraine Glover [Immunisation Nurse Consultant] HUMAN PAPILLOMA VIRUS
More informationCervical screening. Cytology-based screening programmes
HPV-FASTER: broadening the scope for prevention of HPV-related cancer Combining the complementary approaches of HPV vaccination and screening could accelerate declines in the burden of cervical cancer
More informationHPV Immunization, Canadian Perspective
HPV Immunization, Canadian Perspective Mahnaz FarhangMehr Interim Director, Immunization Division Center for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada Outline Background,
More informationHPV Demonstration Programme Update and initial lessons learnt on programme design. HPV Subteam Geneva, Switzerland June 17, 2014
HPV Demonstration Programme Update and initial lessons learnt on programme design HPV Subteam Geneva, Switzerland June 17, 2014 Most recent data on cervical cancer shows higher mortality in less developed
More informationGavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework
Gavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework I. Purpose This Framework sets out the principles and several essential requirements for Gavi s Health
More informationHealth Technology Assessment and the Demands of the Fourth Hurdle Experiences from TLV in Sweden
1 Health Technology Assessment and the Demands of the Fourth Hurdle Experiences from TLV in Sweden Ulf Persson IHE, The Swedish Institute for Health Economics & Institute of Economic Research, School of
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES. COMMISSION STAFF WORKING DOCUMENT on Joint procurement of vaccine against influenza A(H1N1)
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 15.9.2009 SEC(2009) 1188 final COMMISSION STAFF WORKING DOCUMENT on Joint procurement of vaccine against influenza A(H1N1) Accompanying document to the
More informationb de HPV Vaccination of School-Age Girls comparing the cost-effectiveness of 3 delivery programmes SUMMARY
b de HPV Vaccination of School-Age Girls comparing the cost-effectiveness of 3 delivery programmes SUMMARY Human papillomaviruses (HPV) are common sexually transmitted viruses. They can cause several types
More informationThe English immunization programme
The English immunization programme Mary Ramsay Head of Immunisation Public Health England National Health Service Constitution (2009) You have the right to receive the vaccinations that the Joint Committee
More informationState of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report
State of the Art of Rare Disease Activities in EU Member States and Other European Countries Slovak Republic Report Definition of a Rare Disease The Slovak Republic has adopted the European Commission
More informationPOSITION PAPER PALLIATIVE CARE, PEDIATRIC PALLIATIVE CARE AND PAIN THERAPY: HUMANIZATION OF CARE
POSITION PAPER 1 PALLIATIVE CARE, PEDIATRIC PALLIATIVE CARE AND PAIN THERAPY: HUMANIZATION OF CARE GROUP LEADER: Basilicata Region OTHER PARTNERS: Calabria; Campania; Lazio; Marche; Piemonte; Prov. Aut.
More informationANNEX 07 - LATVIA MEDIA GUIDE on CERVICAL CANCER IN LATVIA
European Commission Directorate C Public Health and Risk Assessment Health & Consumer Protection Directorate general GRANT AGREEMENT n 2007121 EUROCHIP-III European Cancer Health Indicator Project-III
More informationSTRATEGIC APPROACH & WORKPLAN 2007
Rare Diseases Europe STRATEGIC APPROACH 2007-2009 & WORKPLAN 2007 Paris, March 2007 www.eurordis.org Contents Our strategic approach 2007 2009 o Eurordis in 2010 o Strategic orientations o Priorities 2007-2009
More informationGavi Risk Appetite Statement Version 2.0
Gavi Risk Appetite Statement Version 2.0 DOCUMENT ADMINISTRATION VERSION NUMBER 1.0 2.0 APPROVAL PROCESS Reviewed and recommended by: Gavi Programme & Policy Committee Reviewed and approved by: Gavi, the
More informationWHO Global Strategies in Cervical Cancer Prevention and Control
WHO Global Strategies in Cervical Cancer Prevention and Control Dr. JM. DANGOU WHO-AFRO 1 Regional Conference on New Opportunities and Innovations in Cervical Cancer prevention Cervical Cancer burden Age-standardised
More informationHPV year 1 in Quebec Different perspectives, different outcomes. Monique Landry MD Ministry of Health of Quebec June 2009
HPV year 1 in Quebec Different perspectives, different outcomes Monique Landry MD Ministry of Health of Quebec June 2009 Outline The program The preparation The results The hypothesis The evaluation THE
More informationGAVI, THE VACCINE ALLIANCE
#vaccineswork GAVI, THE VACCINE ALLIANCE Partnerships for Health Outcomes Susan Brown July, 2017, New York Gavi/2012/Doune Porter www.gavi.org 1 ABOUT GAVI Gavi s mission: to save children s lives and
More informationEconomic and Social Council
United Nations Economic and Social Council Distr.: General 18 November 2014 Original: English Economic and Social Commission for Asia and the Pacific Asia-Pacific Intergovernmental Meeting on HIV and AIDS
More informationAnalysis on Annual Reports 2011 Victim Support Europe Members
Victim Support Europe September 2012 No 3/2012 Analysis on Annual Reports 2011 Victim Support Europe Members Introduction Victim Support Europe, in an effort to summarise the achievements, efforts, progresses
More informationEUROPEAN GUIDE ON QUALITY IMPROVEMENT IN COMPREHENSIVE CANCER CONTROL
EUROPEAN GUIDE ON QUALITY IMPROVEMENT IN COMPREHENSIVE CANCER CONTROL Policy Paper on National Cancer Control Programmes (NCCPs)/ Cancer Documents in Europe Marjetka Jelenc, Tit Albreht, Karen Budewig,
More informationLocal CQUIN Template School Aged Immunisation Programmes
Local CQUIN Template Aged Immunisation Programmes 2017-2019 Indicator number Indicator name Aged Immunisation Programmes 2017-2019: Ensuring a wide spread of good coverage Indicator weighting (% of CQUIN
More informationTALKING POINTS INTRODUCTION
TALKING POINTS INTRODUCTION I have been asked by Amina to talk about health and development and to share some of the experiences of the GAVI Alliance model that might be replicated in furtherance of other
More information2018 INFUSE CALL FOR INNOVATION
2018 INFUSE CALL FOR INNOVATION Leveraging digital technologies for registration, identification, digital record-keeping and follow-up to ensure healthier futures Imagine a future in which all children
More informationContribution from the Danish Ministry of Food, Fisheries and Agriculture on the Commission hearing 1 ;
Ministeriet for Fødevarer, Landbrug og Fiskeri Direktoratet for FødevareErhverv 29.02.2008/EUK Contribution from the Danish Ministry of Food, Fisheries and Agriculture on the Commission hearing 1 ; Towards
More informationDECLARATION. Inaugural. Post-2015: Desired Outcomes February 2015 United Nations Headquarters. United Nations
Inaugural Post-2015: Desired Outcomes 11-12 February 2015 Headquarters DECLARATION 1 We, participants gathered at the Inaugural World Women s Health and Development Forum held by the Royal Academy of Science,
More informationReport to the GAVI Alliance Board 7-8 July 2011
Report to the GAVI Alliance Board 7-8 July 2011 Subject: Report of: Authored by: GAVI Matching Fund for Immunisation David Ferreira, MD, Innovative Finance Paolo Sison, Director, Innovative Finance Agenda
More informationVERSION APPROVAL PROCESS NUMBER 1.0 Nina Schwalbe, Managing Director, Policy and Performance
Version No.: 1.0 Page 1 / 5 DOCUMENT ADMINISTRATION VERSION APPROVAL PROCESS DATE NUMBER 1.0 Nina Schwalbe, Managing Director, and Performance Reviewed by: GAVI Programme 23 April 2012 and Committee Approved
More informationAPPROVAL PROCESS 1.0 Approved by: Joint GAVI Alliance & Fund Board
GAVI Alliance Gender Policy Version No.: 1.0 Page 1 / 10 DOCUMENT ADMINISTRATION VERSION NUMBER APPROVAL PROCESS 1.0 Approved by: Joint GAVI Alliance & Fund Board 26 June 2008 DATE Effective from: 1 July
More informationThe Life Course Immunisation Initiative
Contents Case Study... 1 Action Proposed... 3 Methodology... 4 Results... 9 Conclusions... 10 Case Study Background Anyone can contract meningitis and septicaemia, therefore everyone has the right to access
More informationUpdates from the European Centre for Disease Prevention and Control
Updates from the European Centre for Disease Prevention and Control AIRA 2018 National Meeting, Salt Lake City Global Perspectives Plenary session Tarik Derrough Senior Expert Vaccine Preventable Diseases
More informationCancer prevention and control in the context of an integrated approach
SEVENTIETH WORLD HEALTH ASSEMBLY A70/32 Provisional agenda item 15.6 13 April 2017 Cancer prevention and control in the context of an integrated approach Report by the Secretariat 1. In January 2017, the
More informationGAVI, THE VACCINE ALLIANCE
#vaccineswork GAVI, THE VACCINE ALLIANCE Natasha Bilimoria December 2016 National Academy of Sciences www.gavi.org 1 ABOUT GAVI Gavi s mission: to save children s lives and protect people s health by increasing
More informationBUDGET AND RESOURCE ALLOCATION MATRIX
Strategic Direction/Function ILO Strengthened capacity of young people, youth-led organizations, key service providers and partners to develop, implement, monitor and evaluate HIV prevention programmes
More informationExecutive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services
United Nations DP/FPA/CPD/MDA/3 Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 3 July
More informationHPV Vaccination. Dr. Vivien Tsu PATH. HPV Vaccination 1
HPV Vaccination Dr. Vivien Tsu PATH HPV Vaccination 1 HPV vaccine overview 1 First vaccines to focus on a female cancer. Prepared from virus-like particles (VLPs). VLPs are non-infectious. Two vaccines
More informationEssential Medicines for Universal Health Coverage. Highlights of the report
Essential Medicines for Universal Health Coverage Highlights of the report Scope and process Prompted by the 30 th anniversary of the 1985 Nairobi Conference on the Rational Use of Drugs, to ask: 1. What
More informationPlanning an effective HPV vaccination launch: The key indicators for success Joakim Dillner
Planning an effective HPV vaccination launch: The key indicators for success Joakim Dillner Professor of Infectious Disease Epidemiology PI, International HPV Reference Center Director, Swedish Cervical
More information1. The World Bank-GAVI Partnership and the Purpose of the Review
1. The World Bank-GAVI Partnership and the Purpose of the Review 1.1 The new World Bank Group strategy makes a strong case for an expanded World Bank Group role in global and regional dialogue and collective
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 21 October 2009
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 October 2009 MENINGITEC suspension for injection in prefilled syringes meningococcal group C oligosaccharide conjugate
More informationSPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m.
SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m. ISSUES NOTE Improving the Health Outcomes of Women and
More informationCanadian Health Care Systems
Vaccine Decisions: Policy Making and Priority Setting in Canadian Health Care Systems Charlotte Moore Hepburn, MD, FRCPC, FAAP Lead, Child Health Policy Initiative Faculty Pediatrician, Division of Pediatric
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE
More informationIntensifying our efforts towards a world free of the avoidable burden of NCDs
OUTCOME DOCUMENT OF THE HIGH-LEVEL MEETING OF THE GENERAL ASSEMBLY ON THE REVIEW OF THE PROGRESS ACHIEVED IN THE PREVENTION AND CONTROL OF NON- COMMUNICABLE DISEASES Revised version dated 3 July 2014 11.50
More informationDraft resolution submitted by the President of the General Assembly
United Nations A/68/L.53 General Assembly Distr.: Limited 7 July 2014 Original: English Sixty-eighth session Agenda item 118 Follow-up to the outcome of the Millennium Summit Draft resolution submitted
More informationAccess to newly licensed medicines. Scottish Medicines Consortium
Access to newly licensed medicines Scottish Medicines Consortium Modifiers The Committee has previously been provided with information about why the SMC uses modifiers in its appraisal process and also
More information[TRANSLATION] Ministry of Health. Higher Health Council Session XLVI Combined Sections II and III. Meeting of 11th January 2007
[TRANSLATION] Ministry of Health Higher Health Council Session XLVI Combined Sections II and III Meeting of 11th January 2007 The Higher Health Council Combined Sections II and III HAVING REGARD TO the
More information10. Advocacy 11. International activities
SUMMARY REPORT While studying at the Faculty of Medicine, we are witnessing a strong opposition to vaccination, especially on social networks and other online spaces. Students are finding that both, the
More informationHISTORY GREEN CRESCENT SOCIETY
0 HISTORY 1 HISTORY 2 HISTORY 3 ORGANIZATION 4 ORGANIZATION General Assembly Executive Board General Management Green Crescent Branches Green Crescent Representatives 5 ORGANIZATION 37 Branches 101 Representatives
More informationAccelerating action towards elimination of cervical cancer: Social Media Messaging Toolkit
Accelerating action towards elimination of cervical cancer: Social Media Messaging Toolkit 1. Objectives The objectives of this social media toolkit are to support dissemination of the cervical cancer
More informationResolution adopted by the General Assembly. [without reference to a Main Committee (A/62/L.39 and Add.1)]
United Nations General Assembly Distr.: General 7 March 2008 Sixty-second session Agenda item 47 Resolution adopted by the General Assembly [without reference to a Main Committee (A/62/L.39 and Add.1)]
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 24.06.2009 (provisional version) COM(2009) 291/4 COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL
More informationADDRESSING INEQUITIES IN CANCER PREVENTION CALLING FOR HPV VACCINATION FOR BOYS AND GIRLS
ADDRESSING INEQUITIES IN CANCER PREVENTION CALLING FOR HPV VACCINATION FOR BOYS AND GIRLS Co-hosted by Nessa Childers MEP and Karin Kadenbach MEP 25 APRIL 2017 09.00 11.00 AM European Parliament, Room
More informationHuman Papillomavirus Vaccination Programme in Malaysia
2016/SOM3/HWG-LSIF/WKSP/010 Session Human Papillomavirus Vaccination Programme in Malaysia Submitted by: Malaysia Accelerating Action on Human Papillomavirus and Cervical Cancer Prevention and Control
More informationNHS public health functions agreement Service specification No.11 Human papillomavirus (HPV) programme
NHS public health functions agreement 2018-19 Service specification No.11 Human papillomavirus (HPV) programme 1 NHS public health functions agreement 2018-19 Service specification No.11 Human papillomavirus
More informationSPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV
SPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV PREVENTION COALITION MEETING, 10 OCTOBER2017 I have said many times, and wish to repeat, that
More informationThe HPV vaccination programme in Flanders. Geert Top MD Infectious disease control and vaccination
The HPV vaccination programme in Flanders Geert Top MD Infectious disease control and vaccination HPV-vaccination in Belgium From 2007 onwards vaccines available in pharmacies in Belgium Quadrivalent vaccine
More informationExecutive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services
United Nations DP/FPA/CPD/ZMB/8 Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 30 June
More informationThe challenge of vaccine hesitancy in the European Union
The challenge of vaccine hesitancy in the European Union Michael Sulzner AIM SEMINAR Vaccine hesitancy, a global trend which threatens public health 11 December 2017, Brussels Outline - Competence - Political
More informationLessons learnt from cancer screening programmes as an example for establishing the Czech National Coordination Centre
Czech National Coordination Centre for Prevention of Serious Diseases CZ.03.2.63/0.0/0.0/15_039/0006904 Lessons learnt from cancer screening programmes as an example for establishing the Czech National
More informationAdolescent Health programme and its contribution to the success of vaccination. Hungary
Adolescent Health programme and its contribution to the success of vaccination Hungary By Prof. Tamás SIMON President of the Jozsef Fodor School Health Society Budapest Hungary Childhood vaccination schedule
More informationObstacles and opportunities for including males in Canadian human papillomavirus vaccination programs
Obstacles and opportunities for including males in Canadian human papillomavirus vaccination programs Gilla K. Shapiro, Samara Perez, Zeev Rosberger Department of Psychology, McGill University Psychosocial
More informationAssessing the Health Policy Arena
resource from : conducting formative research for hpv vaccination program planning: practical experience from path publication title Assessing the Health Policy Arena publisher PATH publication date 2012
More informationChecklist for assessing the gender responsiveness of sexual and reproductive health policies. Pilot document for adaptation to national contexts
Checklist for assessing the gender responsiveness of sexual and reproductive health policies Pilot document for adaptation to national contexts Address requests about publications of the WHO Regional Office
More informationExcellence comprises openness National Open Access Strategy and OA at the SNSF. Dr. Tobias Philipp
Excellence comprises openness National Open Access Strategy and OA at the Dr. Tobias Philipp Swiss political system and actors Federal and cantonal competencies for higher education institutes: Limited
More informationPneumococcal vaccination for older persons. No. 2018/05. Executive summary
Pneumococcal vaccination for older persons No. 2018/05 Executive summary Executive summary Pneumococcal vaccination for older persons page 2 of 6 Many people carry pneumococcal bacteria without becoming
More informationAgency Report Item 11: Oregon Health Authority Meningitis Vaccination Program in Lane County
Agency Report Item 11: Oregon Health Authority Meningitis Vaccination Program in Lane County Analyst: Linda Ames Request: Acknowledge receipt of a report on the meningitis vaccination program in Lane County.
More informationon the advertising of medicinal products for human use
30. 4. 92 Official Journal of the European Communities No L 113 / 13 COUNCIL DIRECTIVE 92/28/EEC of 31 March 1992 on the advertising of medicinal products for human use THE COUNCIL OF THE EUROPEAN COMMUNITIES,
More informationPREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH
PREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH Vaccines Europe calls for EU leadership to develop a comprehensive EU vaccination strategy aimed to support Member States in implementing effective
More informationExecutive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services
Executive Board of the Development Programme, the Population Fund and the United Nations Office for Project Services Distr.: General 31 July 2014 Original: English Second regular session 2014 2 to 5 September
More informationPerspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU
Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU N. Safrany European Commission Pr. A. Nicoll ECDC 2 nd WHO GAP mtg 12-14 July 2011 Background
More information19th SESSION OF THE SUBCOMMITTEE OF THE EXECUTIVE COMMITTEE ON WOMEN, HEALTH, AND DEVELOPMENT
PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 19th SESSION OF THE SUBCOMMITTEE OF THE EXECUTIVE COMMITTEE ON WOMEN, HEALTH, AND DEVELOPMENT Washington, D.C., USA, 12 14 March 2001 Provisional
More informationConsultation on Strengthened EU cooperation against vaccine preventable diseases
Consultation on Strengthened EU cooperation against vaccine preventable diseases EuroHealthNet is a not-for-profit partnership of public bodies working from local to regional, national, and international
More informationAccess to Medicines in the Context of the Right to Health
Access to Medicines in the Context of the Right to Health An overview and WHO Perspective Human Rights Council SOCIAL FORUM 18 February 2015 Room XII, Palais des Nations, Geneva Zafar Mirza Public Health,
More informationQuestions and answers about HPV. Facts about the virus and the vaccine
Questions and answers about HPV Facts about the virus and the vaccine About the introduction of the human papillomavirus (HPV) vaccine Which countries have introduced the HPV vaccine? Over 100 countries
More informationVaccine Confidence Current Issues and Controversies including HPV vaccine. Dr Brenda Corcoran National Immunisation Office
Vaccine Confidence Current Issues and Controversies including HPV vaccine Dr Brenda Corcoran National Immunisation Office Vaccination beliefs Factors Confidence do not trust vaccine or provider Complacency
More informationReport to the Board 6-7 June 2018
Report to the Board 6-7 June 2018 SUBJECT: Category: PROGRAMME AND POLICY COMMITTEE CHAIR REPORT For Information Section A: Introduction This report provides the Board with an overview of the activities
More information15571/17 YML/ik 1 DG C 1
Council of the European Union Brussels, 11 December 2017 (OR. en) 15571/17 OUTCOME OF PROCEEDINGS From: General Secretariat of the Council On: 11 December 2017 To: Delegations No. prev. doc.: 14446/17
More informationUICC HPV and CERVICAL CANCER CURRICULUM UICC HPV and Cervical Cancer Curriculum Chapter 8.b. Educational policies Prof. Hélène Sancho-Garnier, MD, PhD
UICC HPV and CERVICAL CANCER CURRICULUM 01 Chapter 8.b. Educational policies Directeur Scientifique Epidaure, Département de Recherche en Prévention, CRLC Val d'aurelle Montpellier, France Health education:
More informationBotswana Private Sector Health Assessment Scope of Work
Example of a Scope of Work (Botswana) Botswana Private Sector Health Assessment Scope of Work I. BACKGROUND The Republic of Botswana is a stable, democratic country in Southern Africa with an estimated
More informationWe have a new vaccine: Now what are we going to do with it? Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci
We have a new vaccine: Now what are we going to do with it? Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci Pressures for new vaccine introduction. International institutions. Vaccine manufacturers National
More informationRegional Program Harm Reduction Works Fund It! Baseline assessment. Country: Georgia. Preliminary analysis. 10 October 2014
Regional Program Harm Reduction Works Fund It! Baseline assessment Country: Georgia Preliminary analysis 10 October 2014 Main constraints The formation of representative bodies, such is CCM, is not transparent.
More informationHuman Papillomavirus Immunisation Programme. Background
Human Papillomavirus Immunisation Programme Background Recommending the use of a human papillomavirus (HPV) vaccine was first signalled in the New Zealand Cancer Control Strategy Action Plan 2005-2010.
More informationCancer prevention and control in the context of an integrated approach
SEVENTIETH WORLD HEALTH ASSEMBLY A70/A/CONF./9 Agenda item 15.6 25 May 2017 Cancer prevention and control in the context of an integrated approach Draft resolution proposed by Brazil, Canada, Colombia,
More informationDraft World Cancer Declaration 2008
Draft World Cancer Declaration 2008 A call to action from the global cancer community 1 A worsening global crisis 1. Cancer kills more people than AIDS, TB and malaria combined, and the death toll is set
More informationElimination of Violence against Women in the Pacific Islands
Elimination of Violence against Women in the Pacific Islands Recommendations from the 12 th Triennial Conference of Pacific Women and Fifth Pacific Women s Ministerial Meeting (Rarotonga, Cook Islands,
More informationGavi s Sustainability and Transition Approach
Gavi s Sustainability and Transition Approach Santiago Cornejo Director, Immunisation Financing and Sustainability 13 June 2018 www.gavi.org Countries tend to face various programmatic and financing challenges
More informationUICC HPV and CERVICAL CANCER CURRICULUM. UICC HPV and Cervical Cancer Curriculum Chapter 5. Application of HPV vaccines Prof. Suzanne Garland MD
UICC HPV and CERVICAL CANCER CURRICULUM 01 Chapter 5. Application of HPV vaccines Director of Microbiological Research Director of Clinical Microbiology and Infectious Diseases The Royal Women's Hospital
More informationPrevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008
Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe Lucca, Italy 13-14 March 2008 Objectives Review activities, role, rationale and impact
More informationProposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed
1. Background Proposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed Vaccination certainly constitutes one of the most cost-effective public health interventions implemented
More information2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030
S T A T E M E N T 2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030 World leaders commit to reach three goals and 20 new Fast-Track Targets
More informationThe road towards universal access
The road towards universal access JAN 2006 Issues Paper Requests... that the UNAIDS Secretariat and its Cosponsors assist in facilitating inclusive, country-driven processes, including consultations with
More informationMidland Region All Boards Development Days. Midland Cancer Network. 15, 16 October, 2015
Midland Region All Boards Development Days Midland Cancer Network 15, 16 October, 2015 NZ cancer incidence 1948-2011 Source: NZ Cancer 0.0 50.0 100.0 150.0 200.0 250.0 300.0 350.0 400.0 0 5000 10000 15000
More informationThe power of innovation to save lives
Innovative Finance The power of innovation to save lives May 2013 The challenge Life or death for a young child too often depends on whether he is born in a country where vaccines are available or not.
More informationTobacco-Control Policy Workshop:
Tobacco-Control Policy Workshop: Goal: to introduce Mega-Country leaders to an effective policy framework for tobacco control and to develop skills to promote policy implementation. Objectives: As a result
More informationDraft of the Rome Declaration on Nutrition
Draft of the Rome Declaration on Nutrition 1. We, Ministers and Plenipotentiaries of the Members of the World Health Organization and the Food and Agriculture Organization of the United Nations, assembled
More informationDecision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
Detiček et al. BMC Health Services Research (2018) 18:496 https://doi.org/10.1186/s12913-018-3299-z RESEARCH ARTICLE Open Access Decision-making criteria for medicine reimbursement in Slovenia: an expert
More information